AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ)
$16.9 -0.06 (-0.3538%)
Analysed AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ) News Sources
Aurinia Settles Patent Litigation with Teva
19-08-2026
yahoo.com
Aurinia Pharmaceuticals (AUPH) Stock Still Looks Cheap After A 74% Gain
20-08-2026
yahoo.com
Could Aurinia Pharmaceuticals (AUPH) Stock Win Big After its LUPKYNIS Patent Settlement With Teva Pharmaceuticals (TEVA)?
28-08-2026
yahoo.com
Immatics and 4 More Stocks See Action From Activist Investors
04-09-2026
yahoo.com
Aurinia’s (AUPH) Profits Surge While Its One Drug Just Got Company
16-09-2026
yahoo.com
Aurinia Announces Initiation of PRESERVE, a Study Investigating the Combination of LUPKYNIS and Belimumab, Obinutuzumab or Anifrolumab in Patients with Lupus Nephritis
06-07-2026
yahoo.com
AUPH Stock Rallies 6% After-Hours — Here’s Why
19-08-2026
stocktwits.com
Aurinia (AUPH) Moves 6.5% Higher: Will This Strength Last?
23-06-2026
yahoo.com
Is Aurinia Pharmaceuticals Inc. (AUPH) A Good Stock To Buy Now?
29-06-2026
yahoo.com
How Investors Are Reacting To Aurinia Pharmaceuticals (AUPH) Extended Voclosporin Exclusivity And Share Buyback
20-08-2026
yahoo.com
What is the current price of AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ)?
The current price of AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ) is $16.9.
AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ) absolute price change since previous trading day?
The absolute price change of AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ) since the previous trading day is $-0.06.
AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ) percentage price change since previous trading day?
The percentage price change of AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ) since the previous trading day is -0.3538%.
What is the most recent average sentiment score for AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ)?
The most recent average sentiment score for AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ) is 67 out of 100.
What is the most recent average sentiment for AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ)?
The most recent sentiment for AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ) is .
SEC-8K** Filing Available For AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.